Arkolith/Insider Trading/MEIP/Form 4

Winson Bruce Ross

10% OwnerMEI Pharma, Inc. (MEIP) · full profile →Form 4 · filed Sep 25, 2023
Net Buying
Open-Market Buys
$329K
Open-Market Sells
$0
Net Open-Market Flow
$329K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 22, 2023Buy(P)48K$6.85$329K864K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 22, 2023Sell(S)9K$0.15$1K9K

Transaction Codes

P
Open-market purchase
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-23-002232) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for MEI Pharma, Inc.

Build

Ask your agent about MEIP insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000921895-23-002232"
Ask your agent
Use Arkolith to summarize insider buying and selling at MEI Pharma, Inc.
over the last 90 days and cite the filings.